Virus Filtration Market Size, Share, Trends and Forecast, 2028

Industry Prospective:

The global virus filtration market reached USD 3.59 billion in 2021 and is projected to grow with a compound annual growth rate of approximately 11.9 % to reach about USD 7.24 billion by 2028. The report analyzes the virus filtration market’s drivers, restraints, challenges, and the effect they have on the demands during the projection period. In addition, the report offers significant opportunities that could boost the global virus filtration market over the forecast period.

Request Free Sample

Virus Filtration Market: Overview

Virus filtration is a simple, effective, and efficient method of maintaining both non-enveloped and enveloped virus particles on the pores or layers of a polymeric membrane. It has a wide range of applications in continuous biological drug manufacturing, and it's becoming more popular for use in monoclonal antibodies as it allows for smaller facility footprints. Because it has no effect on product quality, it is regarded to be an excellent strategy for manufacturing and increasing the safety of biologics such as vaccines, cell lines, and therapeutic recombinant proteins. This approach also removes blood-borne pathogens from plasma-derived products.

Nowadays, biological drugs such as biosimilars and recombinant vaccines require advanced GMP’s to fall it into all the aspects of drug approval. As the pharmaceutical industry is advancing, many potential biological therapeutic drugs are being introduced to the market. These biological drugs are prone to viral contamination which could lead to huge economic loss to a manufacturer. The virus filters provide an advanced solution to the viral contamination. It is being widely adopted in the production of biological drugs, in stem cell products, medical device, air, and water purification, tissue and tissue products, cellular and gene therapy products.

The prospering biopharmaceutical industry increased capital expenditure on research and increasing government support for pharmaceutical and biotechnology industries are the major driving factors for the virus filtration market. However, the high cost of virus filtration systems and strict government regulations are the major factors restraining the growth of virus filtration market. On the other hand, untapped markets in developing countries and rapid technological advancements in virus filtration solutions are expected to offer lucrative opportunities during the forecast period.

COVID-19 Impact:

The global COVID-19 pandemic has fueled demand for viral filtering equipment, as well as kits and reagents, which are in high demand since the start of the COVID-19 vaccine manufacturing. Virus filtration is gaining traction as a critical step in the development of stem cell products, vaccines, and other biological. CRO's and pharmaceutical firms are anticipated to increase their investments in filters and filtration systems, indicating a positive future for the sector. The market for viral filtering technologies is expected to continue to expand in the next years, prompting biotechnology businesses to engage in R&D. Several businesses are expected to invest in technology developments in order to decrease risk, increase flexibility, and save money. The COVID-19 pandemic has accelerated the trend, with manufacturers increasing manufacturing to meet worldwide demand.

Request Free Sample

Virus Filtration Market: Growth Drivers

Increasing rate of biological drug development is primarily fueling the market growth.

The rise in chronic sickness instances throughout the world has prompted medication developers to create advanced class pharmaceuticals, allowing virus filtering to be used as the foundation technology. It is undeniable that the global disease burden, in respect of chronic illness, has risen. According to the World Health Organization, cancer is responsible for one out of every six deaths globally. Furthermore, diabetes prevalence has tripled in the previous four decades, with an estimated 550 million people worldwide. Chronic diseases can carry with them a slew of other problems, such as renal failure, vision problems, and, finally, heart attacks. The world's major pharmaceutical companies are actively investigating medications and vaccinations that might help to prevent or lessen the severity of the disease. The introduction of new medications necessitates the use of viral filtering techniques in downstream processes, which is therefore allowing the global virus filtration market to expand.

Virus Filtration Market: Restraints

Stringent regulations for the biological process may hamper market growth.

The biological products dealing with the virus are susceptible to environmental hazards, health, and large business losses if not handled correctly. The use of virus filtration techniques is rapidly increasing in biological manufacturing. However, the equipment and process used to filter virus is crucial and need to be monitored and inspected carefully for proper results. This is why the strict laws and regulations for viral filtering product validation are expected to constrain the market to some extent.

Virus Filtration Market: Opportunities

Advent of nanofiber technology expected to offer better growth opportunities for market expansion.

In comparison to the classic electrospinning technique, the new advanced nanofiber coating technology offers higher control, flexibility, and durability in pharmaceutical filtering. Fibers ranging in size from 0.3 to 0.5 microns can be used in this novel coating, which can be raised to 1 micron. The fiber diameter distribution and layer thickness may be readily modified to meet the needs of the application. The NANOWEB advanced nanofiber technology has advantages in both liquid and air filtration, and it can be customized to satisfy the demanding filtering needs of a variety of liquid applications. It also meets the increased need for enhanced microfiltration and ultrafiltration in a wide range of liquid service applications, such as life sciences, process liquid filtration, and food & beverage.

Virus Filtration Market: Challenges

Issues with the continuous filtration process pose a major challenge to market growth.

The virus filter's continuous processing may not operate as expected, resulting in defective batches of items and stifling the global virus filtration market's growth. Virus filtration is an important downstream procedure that may be done in two ways: batch filtration and continuous flow filtration. Because batch systems are closed and more complicated in the continuous viral filtering process, variations in protein content, inconsistent pH values, and conductivity pose a challenge to the virus filter. When the minimum titer was 106 pfu/ml, the filters were also put to the test. Additionally, corporations must pay additional funds to perform parallel filtration, which will allow in-line testing throughout the batch filtration's continuous phase.

Virus Filtration Market: Report Scope

Virus Filtration Market: Segmentation

The global virus filtration market is categorized into product, application, end-user, and region.All the segments of virus filtration market have been analyzed based on present and future trends and the market is estimated from 2022 to 2028.

By product, the global virus filtration market is divided into filtration systems, kits & reagents, services, and others. Among these filtration systems segment was the highest revenue grosser in 2017. Virus filtration is a common unit operation in the manufacture of biological drugs. The increasing the demand for these diagnostic care and CRO’s are expected to poise the growth of kits and reagent in coming years.

On the basis of application, the market is segmented into biologicals, vaccines and therapeutics, blood and blood products, stem cell products, medical device, air purification and water purification, tissue and tissue products, and cellular and gene therapy products.

The end users in the virus filtration market are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. The pharmaceutical and biotechnological companies dominated the market and accounted for the largest share in 2017. The bulky share of this segment is primarily credited to the prime factors such as growing need of virus retention in the product feed and the growing stringent regulatory policies for drug approvals. The contract research organization segment is expected to grow at the highest CAGR during the forecast period.

Based on the geography, the global virus filtration market is divided into five regions, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region over the forecast period. Europe was the second largest market followed by the Asia Pacific. Asia Pacific anticipates being the fastest growing market with the highest CAGR during the forecast period. Developing economies such as India and China are accelerating the growth of this region owing to the development of healthcare infrastructure and heightened corporate investments in the healthcare sector. The Middle East and Africa and Latin America are expected to experience moderate growth in the virus filtration market in the years to come. 

Recent Developments

• August 2021, Honeywell unveiled its coronavirus "drop-in" filter. The following would be in the form of a coating capable of eradicating 97 percent of the Sars-Cov-19 virus. Furthermore, the product introduction is targeted at schools and government offices that already have heating and cooling systems in place and don't want to spend a lot of money on denser filtration.
• February 2021, the first virus-killing air purifier has been released by Estonian UV tech. The gadget is worn around the neck and can filter out 99 percent of viruses & germs. The gadget has been demonstrated to be 99.88 percent effective against E. Coli, as well as 99.44 percent effective against Alphavirus. The procedure is then vented to the user after passing via an internal filter and a germicidal UV-C lamp.

Virus Filtration Market: Regional Landscape

North America to dominate the global market during the forecast period.

In comparison to the other regions, North America's viral filtration market maintained a significant market share of 36 percent. It is due to the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Furthermore, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the following region contains several well-known firms. Secondly, the region's focus over the last year has been on developing resilient infrastructure that will prevent further breakouts which might lead to a new pandemic is also supporting the growth of the market. Conversely, Asia Pacific region provides significant development potential for marketers. It is due to an increase in FDI from biotechnology businesses in countries like India and China. The economies of scale offered by the countries, as well as advantageous trade regulations, are boosting the viral filtering market to new heights. Furthermore, due to growing pollution levels in the majority of the countries in this region, air purification has become a popular topic and field of innovation, allowing viral filtering to flourish.

Virus Filtration Market: Competitive Landscape

Key players functioning in the global virus filtration market include :

• General Electric Company
• Sartorius AG
• Asahi Kasei Medical Co. Ltd.
• Thermo Fischer Scientific Inc.
• Danaher Corporation
• Clean Cell Inc.
• Charles River Laboratories International Inc.
• Wuxi Biologics
• Lonza Group Ltd among others.

Global virus filtration market is segmented as follows:

By Product

• Virus Filtration Systems
• Kits & Reagents
• Services
• Others

By Application

• Medical Devices
• Water Purification
• Air Purification
• Biologicals

By End-User

• Pharmaceuticals & Biotechnology Companies
• Medical Devices Companies
• Research Institutes

• Contract Research Organizations

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa